CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
about
De novo diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: molecular mechanisms and correlation with rituximab sensitivityDifferential gene expression profiling linked to tumor progression of splenic marginal zone lymphoma.An unusual case of Epstein-Barr virus-positive large B-cell lymphoma lacking various B-cell markersBone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.
P2860
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
@en
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
@nl
type
label
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
@en
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
@nl
prefLabel
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
@en
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
@nl
P2093
P2860
P1476
CD20 gene deletion causes a CD20-negative relapse in diffuse large B-cell lymphoma.
@en
P2093
Bungo Saito
Eisuke Shiozawa
Hidekazu Ota
Hidetoshi Nakashima
Hirotsugu Ariizumi
Kouji Yanagisawa
Kunihiko Fukuchi
Mayumi Homma
Shigeru Tomoyasu
Takashi Maeda
P2860
P304
P356
10.1111/J.1600-0609.2012.01838.X
P577
2012-08-25T00:00:00Z